Scott Kinlay։ Cancer and Adverse Outcomes Over 5 Years After Coronary Stenting and Optimal DAPT Duration
Scott Kinlay, Chief of Cardiology at VA Boston Healthcare System and Associate Professor of Medicine at Harvard Medical School, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Just published: Ramael Ohiomoba and Edwin Mandieka’s paper examines the relationship of cancer to adverse outcomes over 5 years after coronary stenting, as well as the optimal duration DAPT.
Key findings were that cancer patients have higher rates of myocardial infarction and major bleeding after PCI compared to non-cancer patients. The analysis also supports a similar duration of DAPT after PCI in cancer patients as non-cancer patients.”
Title: Relationship of cancer and dual antiplatelet duration to long-term risk of ischaemic and bleeding outcomes after percutaneous coronary intervention
Authors: Ramael Ohiomoba, Edwin Mandieka, Melissa M Young, David R Gagnon, Scott Kinlay
Read the Full Article on European Heart Journal.

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support
-
Nov 17, 2026, 23:34Ahmed Bennis: Is Aspirin Therapy Enough for VTE Prevention After Arthroplasty?
-
Nov 17, 2026, 23:33Remi Remakanth: The Role of Transfusion Medicine in HLA Antibody Testing and Transplant Desensitization